B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: Role of ZAP70 determination on bone marrow biopsy specimens

Journal of Clinical Pathology

Volumn 60, Issue 6, 2007, Pages 627-632

  Sabattini, Elena ^a   Orduz, Rocio ^a   Campidelli, Cristina ^a   Zinzani, Pier Luigi ^a   Callea, Vincenzo ^b   Zupo, Simona ^c   Cutrona, Giovanna ^c   Morabito, Fortunato ^d   Ferrarini, Manlio ^c   Pileri, Stefano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d Dell'Annunziata Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE ZAP 70;

ARTICLE; B CELL LYMPHOMA; BLOOD; BONE MARROW BIOPSY; CANCER CELL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROTEIN DETERMINATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BIOPSY; BLOTTING, WESTERN; BONE MARROW; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, B-CELL, CHRONIC; LYMPHOMA, SMALL LYMPHOCYTIC; MALE; MIDDLE AGED; MUTATION; TUMOR MARKERS, BIOLOGICAL; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 34250894404     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.039586     Document Type: Article

References (43)

1. Müller-Hermelink HK, Monserrat E, Catovsky D, et al. Chronic lymphocytic leukaemia/small lymphocytic lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001:127-30.
2. Rozman C, Monteserrat E. Chronic lymphocytic leukemia. N Engl J Med 1995;333:1052-7.
3. Kipps TJ. Chronic lymphocytic leukemia. Curr Opin Hematol 2000;7:223-34.
4. Hamblin T. Chronic lymphocytic leukaemia: one disease or two? Ann Hematol 2002;81:299-303.
5. Rai KR, Wasil T, Iqbal U, et al. Clinical staging and prognostic markers in chronic lymphocytic leukemia. Hematol Oncol Clin North Am 2004;18:795-807.
6. Döhner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343:1910-16.
7. Chevallier P, Penther D, Avet-Loiseau H, et al. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia. Br J Haematol 2002;116:142-50.
8. Krober A, Seiler T, Benner A, et al. V(H) mutation status, CD38 expression level, genomic aberrations and survival in chronic lymphocytic leukemia. Blood 2002;100:1410-16.
9. Stilgenbauer S, Döhner H. Molecular genetics and its clinical relevance. Hematol Oncol Clin North Am 2004;18:827-48.
10. Damle RM, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840-7.
11. Hamblin TJ, Davis Z, Gardiner A, et al. Unmutated IgV(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-54.
12. Tobin G, Thunberg U, Johnson A, et al. Somatically mutated Ig V(H) 3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002;99:2262-4.
13. Keating MJ, Chiorazzi N, Messmer B, et al. Biology and treatment of chronic lymphocytic leukemia. Hematology (Am Soc Hematol Educ Program) 2003;1:153-75.
14. Oscier DG, Gardiner AC, Mould SJ, et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002;100:1177-84.
15. Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001;194:1625-38.
16. Rosenwald A, Alizadeh AA, Windhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001;194:1639-47.
17. Chan AC, Iwashima M, Turck CW, et al. ZAP-70: a 70-kd protein-tyrosine kinase that associates with TCR zeta chain. Cell 1992;712:649-62.
18. Nolz JC, Tschumper RC, Pittner BT, et al. ZAP-70 is expressed by a subset of normal human B-lymhocytes displaying an activated phenotype. Leukemia 2005;19:1018-24.
19. Wiestner A, Rosenwald A, Barry TS, et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003;101:4944-51.
20. Orchard JA, Ibbotson RE, Davis Z, et al. ZAP-70 expression and prognosis in chronic lymphocytic leukemia. Lancet 2004;363:105-11.
21. Calin GA, Liu CG, Sevignani C, et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 2004;101:11755-60.
22. Ferrer A, Ollila J, Tobin G, et al. Different gene expression in immunoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemia. Cancer Genet Cytogenet 2004;153:69- 72.
23. Crespo M, Bosch F, Villamor N, et al. ZAP-70 expression as a surrogate for immunoglobulin variable region mutations in chronic lymphocytic leukemia. N Engl J Med 2003;348:1764-75.
24. Rassenti L, Huynh L, Toy TL, et al. ZAP-70 compared with immunoglobulin heavy chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004;351:893-901.
25. Kim SZ, Chow KU, Kukoc-Zivojnoiv N, et al. Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status. Leuk Lymphoma 2004;45:2037-45.
26. Schroers R, Griesinger F, Trumper L, et al. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia 2005;19:750-8.
27. Morabito F, Cutrona G, Matis S, et al. Relationship between ZAP-70 and CD38 expression, and mutational status of immunoglobulin heavy-chain variable region in predicting treatment free survival in chronic lymphocytic leukemia [abstract]. Hematologica 2005;27.
28. Admirand JH, Rassidakis GZ, Abruzzo LV, et al. Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma. Mod Pathol 2004;17:954-61.
29. Carreras J, Villamor N, Colomo L, et al. Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms. J Pathol 2005;205:507-13.
30. O'Connor SJM, Starczynski J, Teasdale J, et al. Can ZAP-70 protein expression in B-CLL as detected by immunohistochemistry predict VH mutation status? [Abstract]. Blood 2003;102:34.
31. Morabito F, Mangiola M, Oliva B, et al. Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia. Leuk Res 2001;25:927-32.
32. Del Poeta G, Maurillo L, Venditti A, et al. Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood 2001;98:2633-9.
33. Ibrahim S, Keating M, Do KA, et al. CD38 expression as important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 2001;98:181-6.
34. Hamblin TJ, Orchard JA, Ibbotson RE, et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia but CD38 expression may vary during the course of disease. Blood 2002;99:1023-9.
35. Mainou-Fowler T, Dignum HM, Proctor SJ, et al. The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (B-CLL). Leuk Lymphoma 2004;45:455-62.
36. Vilpo J, Tobin G, Hulkkonen J, et al. Surface antigen, expression and correlation with variable heavy-chain gene mutation status in chronic lymphocytic leukemia. Eur J Haematol 2003;70:53-9.
37. Pileri SA, Ascani S, Milani M, et al. Acute leukaemia immunophenotyping in bone marrow routine sections. Br J Haematol 1999;105:394-401.
38. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984;32:219-29.
39. Sabattini E, Bisgaard K, Ascani S, et al. The EnVision™+ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate™, CSA, IABC and SABC techniques. J Clin Pathol 1998;51:506-11.
40. Messmer BT, Messmer D, Allen SL, et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 2005;115:755-64.
41. Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998;102:1515-25.
42. Tefferi A, Bartholomai BJ, Witzig TE, et al. Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia. Am J Clin Pathol 1996;106:457-61.
43. Pileri SA, Sabattini E, Agostinelli C, et al. Histopathology of B-cell chronic lymphocytic leukemia. Hematol Oncol Clin North Am 2004;18:807-26.